Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-EN
Language English English
Date Updated 2022-04-06 2022-03-25
Drug Identification Number 02246795 02246795
Brand name KETAMINE HYDROCHLORIDE INJECTION USP KETAMINE HYDROCHLORIDE INJECTION USP
Common or Proper name KETAMINE HCL KETAMINE HCL
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients KETAMINE KETAMINE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 20ML 1LIVI 20ML 1LIVI
ATC code N01AX N01AX
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-25 2022-03-25
Estimated end date 2022-04-08 2022-04-08
Actual end date 2022-04-05
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments